Synklino raises €29.8M to trial cytomegalovirus drug - Labiotech.eu

Retrieved on: 2022-06-08 14:02:01

Tags for this article:

Click the tags to see associated articles and topics

Synklino raises €29.8M to trial cytomegalovirus drug - Labiotech.eu. View article details on hiswai:

Excerpt

Danish biotech Synklino has completed a Series A fundraising round that netted ... it can cause issues for those with weakened immune systems.

Article found on: www.labiotech.eu